| Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml (NCT02471105) | Universitaire Ziekenhuizen KU Leuven | 2015-09-01 |
| Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension (NCT02801617) | Laboratorios Sophia S.A de C.V. | 2015-09-01 |
| Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension (NCT02507687) | AbbVie | 2015-08-27 |
| An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert (NCT02537015) | ForSight Vision5, Inc. | 2015-08-10 |
| SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) (NCT02419508) | Alcon Research | 2015-08-07 |
| A Phase I Clinical Trial of DARC (NCT02394613) | University College, London | 2015-05-01 |
| Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy (NCT02434250) | University of Zurich | 2015-05-01 |
| Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) (NCT02339584) | Alcon Research | 2015-04-14 |
| Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma (NCT02379208) | Turku University Hospital | 2015-04-01 |
| Dose-Ranging Study of the Bimatoprost Ocular Insert (NCT02358369) | ForSight Vision5, Inc. | 2015-01-19 |
| Survey of Patients Taking IOP-Lowering Eye Drops (NCT02384772) | ForSight Vision5, Inc. | 2015-01-01 |
| Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT02250651) | Allergan | 2014-12-15 |
| Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension (NCT02247804) | Allergan | 2014-12-15 |
| Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients (NCT02278614) | Laboratoires Thea | 2014-12-01 |
| Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution (NCT02325518) | Alcon, a Novartis Company | 2014-12-01 |
| Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT02312544) | Ocular Therapeutix, Inc. | 2014-11-01 |
| A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT02348476) | Allergan | 2014-11-01 |
| The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface (NCT02295358) | University of Colorado, Denver | 2014-11-01 |
| SYL040012, Treatment for Open Angle Glaucoma (NCT02250612) | Sylentis, S.A. | 2014-10-01 |
| Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma (NCT02338362) | University Health Network, Toronto | 2014-09-01 |
| Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension (NCT02993445) | Temple University | 2014-09-01 |
| 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma (NCT02628223) | Temple University | 2014-09-01 |
| Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT02246764) | Aerie Pharmaceuticals | 2014-09-01 |
| Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study (NCT02390245) | Wills Eye | 2014-09-01 |
| The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure (NCT02165631) | University of Colorado, Denver | 2014-08-01 |
| Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) (NCT02167035) | Cornerstone Health Care, PA | 2014-08-01 |
| Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT02207491) | Aerie Pharmaceuticals | 2014-07-01 |
| An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product (NCT02143843) | ForSight Vision5, Inc. | 2014-06-05 |
| Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (NCT02179008) | Santen Inc. | 2014-06-01 |
| The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. (NCT01927406) | Stanford University | 2014-06-01 |
| A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension (NCT02102750) | Santen Oy | 2014-06-01 |
| 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT02140060) | Alcon Research | 2014-06-01 |
| Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma (NCT03534882) | Cindy Hutnik | 2014-05-27 |
| A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) (NCT02083289) | Ono Pharmaceutical Co., Ltd. | 2014-05-01 |
| A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT02129673) | ViSci Ltd. | 2014-05-01 |
| Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension (NCT02097719) | Allergan | 2014-05-01 |
| Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers (NCT02108288) | Otsuka Pharmaceutical Co., Ltd. | 2014-04-01 |
| Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension (NCT02105285) | Otsuka Pharmaceutical Co., Ltd. | 2014-04-01 |
| Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension (NCT02105272) | Otsuka Pharmaceutical Co., Ltd. | 2014-04-01 |
| Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT02136940) | Amakem, NV | 2014-04-01 |
| Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension (NCT02047630) | CHU de Quebec-Universite Laval | 2014-01-01 |
| Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT02059278) | Nephron Pharmaceuticals Corporation | 2014-01-01 |
| Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose (NCT02017327) | Laboratoires Thea | 2013-12-01 |
| Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure (NCT02003391) | Alcon Research | 2013-12-01 |
| A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (NCT02014142) | Mati Therapeutics Inc. | 2013-12-01 |
| IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients (NCT02030886) | Sensimed AG | 2013-12-01 |
| A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting (NCT01999348) | Allergan | 2013-11-25 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension (NCT01915940) | ForSight Vision5, Inc. | 2013-10-23 |
| A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension (NCT01943721) | ForSight Vision5, Inc. | 2013-10-01 |
| Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue (NCT01937312) | Alcon Research | 2013-10-01 |
| Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® (NCT01937299) | Alcon Research | 2013-10-01 |
| An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More (NCT01979913) | Dr. Anton Hommer | 2013-10-01 |
| Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT01978600) | Alcon Research | 2013-10-01 |
| Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study (NCT01975714) | Association for Innovation and Biomedical Research on Light and Image | 2013-10-01 |
| A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects (NCT02003547) | Amakem, NV | 2013-09-01 |
| A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma (NCT01936389) | Robert Ritch, MD, LLC. | 2013-09-01 |
| Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma (NCT01995136) | Alcon Research | 2013-09-01 |
| Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT (NCT01895972) | Bausch & Lomb Incorporated | 2013-07-05 |
| Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects (NCT01864642) | University of Wisconsin, Madison | 2013-07-01 |
| A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension (NCT01830140) | Allergan | 2013-07-01 |
| Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost (NCT01896180) | Alleanza Pharmaceuticals, Inc. | 2013-07-01 |
| Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01284166) | Allergan | 2013-07-01 |
| An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension (NCT01881126) | Allergan | 2013-06-01 |
| A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension (NCT01863953) | Allergan | 2013-06-01 |
| A Study of Bimatoprost 0.01% in the Clinical Setting (NCT01814761) | Allergan | 2013-05-01 |
| A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons (NCT01853085) | Allergan | 2013-04-01 |
| An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments (NCT01735214) | Allergan | 2013-03-07 |
| IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients (NCT01886456) | University of Zurich | 2013-02-01 |
| Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia (NCT01696383) | Alcon Research | 2013-02-01 |
| A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days (NCT01789736) | Aerie Pharmaceuticals | 2013-02-01 |
| Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT01749930) | Bausch & Lomb Incorporated | 2013-01-01 |
| Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients (NCT01658839) | Alcon Research | 2013-01-01 |
| Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension (NCT01987323) | Singapore Eye Research Institute | 2013-01-01 |
| A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension (NCT01781962) | Allergan | 2013-01-01 |
| Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH (NCT01721707) | Adapt Produtos Oftalmológicos Ltda. | 2012-12-01 |
| Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure (NCT01731002) | Aerie Pharmaceuticals | 2012-11-01 |
| BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT01707381) | Bausch & Lomb Incorporated | 2012-11-01 |
| A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months (NCT01699464) | Aerie Pharmaceuticals | 2012-10-01 |
| Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea (NCT03928665) | Wroclaw Medical University | 2012-10-01 |
| An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation (NCT01719809) | Robin, Alan L., M.D. | 2012-10-01 |
| Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension (NCT03395535) | Moorfields Eye Hospital NHS Foundation Trust | 2012-10-01 |
| An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® (NCT01664039) | Alcon Research | 2012-09-01 |
| Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma (NCT01693315) | Amakem, NV | 2012-09-01 |
| ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects (NCT01668524) | Altheos, Inc. | 2012-08-01 |
| Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma (NCT01739244) | Sylentis, S.A. | 2012-07-01 |
| Ocular Hypertension And Yoga Study (NCT01446588) | Johns Hopkins University | 2012-06-01 |
| A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT01646151) | Allergan | 2012-05-01 |
| A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01589510) | Allergan | 2012-04-01 |
| Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure (NCT01779778) | University of Colorado, Denver | 2012-04-01 |
| A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) (NCT01594970) | Allergan | 2012-03-01 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (NCT01528111) | Lexicon Pharmaceuticals | 2012-03-01 |
| Study of AR-13324 in Patients With Elevated Intraocular Pressure (NCT01528787) | Aerie Pharmaceuticals | 2012-03-01 |
| Efficacy of Changing to TRAVATAN® From Prior Therapy (NCT01510145) | Alcon Research | 2012-02-01 |
| Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery (NCT03201354) | Institut Catala de Retina | 2012-02-01 |
| Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) (NCT01540370) | Allergan | 2012-02-01 |
| Travacom Post Marketing Surveillance Study (NCT01510132) | Alcon Research | 2012-01-01 |
| A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension (NCT01525173) | Allergan | 2012-01-01 |
| Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (NCT01520116) | Altheos, Inc. | 2012-01-01 |
| Efficacy of Changing to TRAVATAN® From Prior Therapy (NCT01493427) | Alcon Research | 2011-12-01 |
| AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure (NCT01474135) | Aerie Pharmaceuticals | 2011-12-01 |